News
The pharma sector was spared from Trump's sweeping tariff plan last week, which kicked in on Wednesday, but the U.S. president had previously pledged to impose tariff on pharma products and his ...
The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...
Jazz Pharmaceuticals said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem.
23h
Zacks Investment Research on MSNEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowEli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
UVA professor Dr. Christopher Kramer explains how a new Eli Lilly drug may cut a significant heart attack risk factor by 95%.
Eli Lilly (LLY) stock gains as Goldman Sachs upgrades it to Buy from Neutral citing the company's leadership position in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results